Metoprolol and weight gain
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol and Weight Gain: Effects in Different Patient Populations
Metoprolol and Weight Gain in Patients with Diabetes and Hypertension
Research shows that metoprolol tartrate is associated with significant weight gain in patients with type 2 diabetes and hypertension. In a large study, patients taking metoprolol gained an average of 1.19 kg over five months, while those on carvedilol did not experience significant weight gain. The effect was more pronounced in patients with higher body mass index (BMI), especially those who were obese or morbidly obese. Importantly, this weight gain was not linked to changes in blood sugar control or blood pressure, suggesting a direct effect of metoprolol on body weight rather than an indirect effect through these factors .
Metoprolol and Weight Changes in Chronic Heart Failure and Cachexia
In patients with chronic heart failure (CHF) who are experiencing cachexia (a condition of severe weight loss and muscle wasting), metoprolol therapy has been shown to help reverse weight loss. Studies found that after six months of metoprolol or other beta-blocker therapy, cachectic patients gained significantly more weight compared to non-cachectic patients. This weight gain was accompanied by improvements in certain hormone levels and a reduction in markers of inflammation, suggesting that metoprolol may help improve nutritional status and reduce inflammation in this specific group Shan-Jun2006Hryniewicz2003.
Genetic Factors, Obesity, and Metoprolol Response
The response to metoprolol in patients with both CHF and obesity can vary based on genetic differences. One study found that patients with a specific genetic variant (the GG genotype of the CYP2D6 gene) experienced better clinical outcomes and improvements in heart function with metoprolol, while those with the GA genotype were more likely to experience weight gain and side effects. This suggests that genetics may influence both the effectiveness and the side effects of metoprolol, including its impact on body weight in obese patients .
Metoprolol Compared to Weight Reduction for Hypertension
In overweight patients with mild hypertension, weight reduction through lifestyle changes led to significant weight loss and better blood pressure control compared to metoprolol treatment. While metoprolol effectively lowered blood pressure, it did not result in weight loss and was associated with less favorable changes in cholesterol levels. This highlights that lifestyle interventions may be preferable for weight management and cardiovascular risk reduction in overweight hypertensive patients .
Metoprolol in Combination Therapies for Obesity
A recent study tested a combination of tesofensine and metoprolol (Tesomet) in adults with hypothalamic obesity. The combination therapy resulted in significant weight loss compared to placebo, without affecting heart rate or blood pressure. This suggests that when used as part of a combination therapy, metoprolol does not prevent weight loss and may be safe in this context .
Conclusion
Metoprolol is associated with weight gain in patients with diabetes and hypertension, especially in those who are already overweight or obese. However, in patients with chronic heart failure and cachexia, metoprolol may help reverse weight loss. Genetic factors can influence how metoprolol affects weight, and lifestyle interventions remain the most effective strategy for weight loss in overweight hypertensive patients. When used in combination therapies for specific conditions like hypothalamic obesity, metoprolol does not appear to hinder weight loss. Overall, the impact of metoprolol on weight depends on the patient population and individual factors.
Sources and full results
Most relevant research papers on this topic